BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 28465482)

  • 1. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
    Tian Y; Li Z; Shen B; Zhang Q; Feng H
    Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury.
    Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y
    Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
    Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
    J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Pan CW; Pan ZZ; Hu JJ; Chen WL; Zhou GY; Lin W; Jin LX; Xu CL
    Eur J Pharmacol; 2016 Jan; 770():85-91. PubMed ID: 26668000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
    Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
    Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
    Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
    Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
    Huang H; Zhang X; Li J
    J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation.
    Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB
    Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
    Zhu Y; Chen X; Rao X; Zheng C; Peng X
    Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
    Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H
    Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
    Li J; Zhang X; Huang H
    Int Immunopharmacol; 2014 Dec; 23(2):523-9. PubMed ID: 25311666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
    Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
    Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-
    Xu L; Yu Y; Sang R; Li J; Ge B; Zhang X
    Oxid Med Cell Longev; 2018; 2018():8284107. PubMed ID: 30344887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
    Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
    Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
    Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
    Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.